Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug Induced Parkinsonism”

28 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 28 results

Testing effectiveness (Phase 2)Study completedNCT02657681
What this trial is testing

Prevention of Levodopa-induced Dyskinesias by Transcranial Static Magnetic Field Stimulation (tSMS)

Who this might be right for
Dyskinesia, Medication-InducedParkinson's Disease
Fundación de investigación HM 50
Not applicableStudy completedNCT00368199
What this trial is testing

Transcranial Duplex Scanning and Single Photon Emission Computer Tomography (SPECT) in Parkinsonian Syndromes

Who this might be right for
Parkinson's DiseaseParkinsonian SyndromeMultiple System Atrophy+4 more
Maastricht University Medical Center 196
Not applicableStudy completedNCT02598973
What this trial is testing

Effect of Exercise in Parkinsonism

Who this might be right for
Parkinson's DiseaseDrug-induced Parkinsonism
VA Office of Research and Development 9
Not applicableLooking for participantsNCT06570824
What this trial is testing

RTMS as an Intervention for Levodopa-induced Dyskinesia

Who this might be right for
Dyskinesia, Drug-InducedParkinson Disease
Danish Research Centre for Magnetic Resonance 68
Large-scale testing (Phase 3)Ended earlyNCT05116813
What this trial is testing

Open-label Safety Study of Dipraglurant (ADX48621) in Patients With Parkinson's Disease Receiving Levodopa-based Therapy

Who this might be right for
Parkinson DiseaseDyskinesia, Drug-InducedDyskinesias
Addex Pharma S.A. 17
Testing effectiveness (Phase 2)Study completedNCT01092065
What this trial is testing

Efficacy and Safety of AFQ056 When Combined With Increased Doses of L-dopa in Parkinson's Disease Patients With Moderate-severe L-dopa Induced Dyskinesia

Who this might be right for
Parkinson's Disease
Novartis 23
Post-approval studies (Phase 4)Looking for participantsNCT03495024
What this trial is testing

Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates

Who this might be right for
SchizophreniaSchizoaffective DisorderTobacco Smoking+2 more
Corporal Michael J. Crescenz VA Medical Center 10
Not applicableLooking for participantsNCT06949865
What this trial is testing

AI-Enhanced Optimization of Acute Levodopa Challenge Test

Who this might be right for
Vascular ParkinsonismDrug-induced ParkinsonismCorticobasal Degeneration (CBD)+4 more
Beijing Tiantan Hospital 2,000
Not applicableStudy completedNCT04064294
What this trial is testing

Preventing Levodopa Induced Dyskinesia in Parkinson's Disease With HMG-CoA Reductase Inhibitors

Who this might be right for
Parkinson DiseaseDyskinesia, Drug-Induced
VA Office of Research and Development 93
Testing effectiveness (Phase 2)Ended earlyNCT01789047
What this trial is testing

Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's DiseaseDrug Induced Dyskinesia
Rush University Medical Center 42
Testing effectiveness (Phase 2)Ended earlyNCT00686699
What this trial is testing

Study of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Participants With Schizophrenia (Study P04628)

Who this might be right for
Akathisia, Drug-InducedDyskinesia, Drug-InducedParkinsonian Disorders
Merck Sharp & Dohme LLC 11
Not applicableStudy completedNCT01429207
What this trial is testing

Capturing Parkinson's Disease Medication Side Effects During Daily Activities

Who this might be right for
Parkinson's DiseaseDyskinesia
Great Lakes NeuroTechnologies Inc. 15
Testing effectiveness (Phase 2)UnknownNCT04147949
What this trial is testing

AV-101 (L-4-chlorokynurenine) in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesia

Who this might be right for
Parkinson DiseaseDyskinesia, Medication-InducedL-Dopa Causing Adverse Effects in Therapeutic Use
VistaGen Therapeutics, Inc. 20
Testing effectiveness (Phase 2)UnknownNCT03944447
What this trial is testing

Outcomes Mandate National Integration With Cannabis as Medicine

Who this might be right for
Chronic PainChronic Pain SyndromeChronic Pain Due to Injury+30 more
OMNI Medical Services, LLC 200,000
Not applicableStudy completedNCT00955604
What this trial is testing

Azilect + Antidepressant Chart Review

Who this might be right for
Serotonin Syndrome
Teva Branded Pharmaceutical Products R&D, Inc. 1,500
Not applicableActive Not RecruitingNCT02252380
What this trial is testing

ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders

Who this might be right for
Movement DisordersEssential TremorHolmes Tremor+6 more
InSightec 10
Not applicableLooking for participantsNCT05317390
What this trial is testing

Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia

Who this might be right for
DystoniaDrug Induced DystoniaParkinson Disease+8 more
Massachusetts Eye and Ear Infirmary 1,000
Not applicableStudy completedNCT03354455
What this trial is testing

Investigating the Causal Role of preSMA in Levodopa-induced Dyskinesia in Parkinson's Disease

Who this might be right for
Dyskinesia, Drug-InducedParkinson Disease
Danish Research Centre for Magnetic Resonance 20
Large-scale testing (Phase 3)WithdrawnNCT03987750
What this trial is testing

Safinamide for Levodopa-induced Dyskinesia (PD-LID)

Who this might be right for
Dyskinesia, Drug-InducedParkinson Disease
Zambon SpA
Early research (Phase 1)Enrolling By InvitationNCT06344026
What this trial is testing

Phase 1/2a Study of ANPD001 in Parkinson Disease

Who this might be right for
Parkinson Disease
Aspen Neuroscience 9
Load More Results